Part-Time

Optometrist

Vitreous-Retina-Macula Consultants of New York PC

Vitreous-Retina-Macula Consultants of New York PC

11-50 employees

Specializes in vitreoretinal diagnosis and surgery

Compensation Overview

$75 - $80/hr

New York, NY, USA

In Person

MD

Category
Medical, Clinical & Veterinary
Required Skills
Electronic Health Records (EHR)
Patient Education

Get referred to Vitreous-Retina-Macula Consultants of New York PC

See people who can refer or advise you

Requirements
  • A Doctor of Optometry degree from an accredited institution.
  • An active and unrestricted New York State Optometry license.
  • Strong clinical proficiency in ocular surface disease.
  • A proven drive for patient education, practice building, and community outreach to help scale the primary care footprint.
  • Exceptional clinical bedside manner with clear, compassionate communication skills.
Responsibilities
  • Lead the clinical expansion of the optometry and dry eye practice, utilizing advanced modalities to build a robust patient base.
  • Perform comprehensive eye examinations for a diverse patient base, diagnosing and managing primary eye care needs.
  • Diagnose, manage, and implement specialized treatment protocols for ocular surface disease and dry eye syndrome.
  • Educate patients on long-term eye health, preventative care, and specialized or elective dry eye therapies.
  • Actively engage in practice-building initiatives and community outreach to drive new patient acquisition and local referrals.
  • Partner with ophthalmologists and retina specialists to ensure seamless continuity of care.
  • Maintain clear, accurate, and timely electronic health records.
Desired Qualifications
  • Advanced certifications or residency training in dry eye management.
Vitreous-Retina-Macula Consultants of New York PC

Vitreous-Retina-Macula Consultants of New York PC

View

VRMNY provides specialized retinal care in New York, diagnosing and treating retinal diseases such as macular degeneration and diabetic retinopathy, and performing vitreoretinal surgeries including vitrectomy. Patients receive medical management and surgical treatment across its Manhattan and Downtown centers, with care coordinated by a team of retina specialists. The group stands out through its physicians’ international recognition, academic appointments at Lenox Hill Hospital, NYU, and NY Eye and Ear Infirmary, and its status as the largest retina-vitreous center in the NYC area. The goal is to diagnose, treat, and manage retinal diseases to preserve and restore vision for patients across multiple locations.

Company Size

11-50

Company Stage

N/A

Total Funding

N/A

Headquarters

New York City, New York

Founded

1974

Get referred to Vitreous-Retina-Macula Consultants of New York PC

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Aug. 19, 2026 recruitment opened for MAKO and BOULEVARD studies, expanding pipeline.
  • Aug. 6, 2026 hire Marc Mardelli adds capacity in Scarsdale and New City.
  • Apr. 15, 2026 Castle Connolly named all 19 physicians Top Doctors, strengthening prestige.

What critics are saying

  • A handful of star physicians anchor the brand; departures would crush referral flow.
  • AUG 2026 trial recruitment depends on external sponsors like Regenxbio and Roche.
  • Private-practice retina margins face insurer pressure; one reimbursement shock hits every location.

What makes Vitreous-Retina-Macula Consultants of New York PC unique

  • VRMNY concentrates elite retina subspecialists across Manhattan, Brooklyn, and Westchester.
  • Its physicians include Spaide, Freund, Yannuzzi, and Fisher, drawing complex referral volume.
  • The practice runs active wet AMD and DME trials, deepening clinical credibility.

Help us improve and share your feedback! Did you find this helpful?

Benefits

401(k) Company Match

Dental Insurance

Flexible Spending Account

Health Insurance

Life Insurance

Parental Leave

Health Savings Account

Vision Insurance

Company News

PR Newswire
Feb 20th, 2024
Richard F. Spaide, Md Of The Vitreous Retina Macula Consultants Of New York Awarded The Arnall Patz Medal By The Macula Society

NEW YORK, Feb. 20, 2024 /PRNewswire/ -- Vitreous Retina Macula Consultants of New York ( VRMNY ), the largest retina vitreous center in the New York Metropolitan area, has announced that its esteemed ophthalmologist Richard F. Spaide, MD, was awarded the Arnall Patz Medal at The Macula Society 's 47th Annual Meeting on February 9th, 2024.Dr. Spaide was selected as the honoree of the Arnall Patz Medal by the awards committee of The Macula Society. The Macula Society is the preeminent organization for specialists in the field of macula and retinal diseases. The Arnall Patz Medal is awarded to those who have made outstanding contributions to the understanding of retinal vascular diseases in honor of ophthalmologist Arnall Patz, who is known for his landmark work on retinopathy of prematurity.Dr

PR Newswire
Jan 5th, 2024
Vitreous Retina Macula Consultants Of New York'S K. Bailey Freund, Md Serves As Program Director Of The Atlantic Coast Retina Club (Acrc) And Macula Conference

NEW YORK, Jan. 5, 2024 /PRNewswire/ -- Vitreous Retina Macula Consultants of New York ( VRMNY ), the largest retina vitreous center in the New York Metropolitan area, has announced that its esteemed ophthalmologist K. Bailey Freund, MD will serve as the Program Director of the 48th Annual Atlantic Coast Retina Club (ACRC) & 24th Macula Conference (Macula 2024).The ACRC was originally co-founded by Lawrence Yannuzzi, MD, co-founder of VRMNY, as a one-day Friday conference open to all retinal specialists. Twenty-three years after the first ACRC meeting, Dr. Yannuzzi created a Saturday program and Macula 2000 was born.The Conference will take place from January 4th through the 6th at the New York Academy of Medicine, 1216 5th Avenue in New York City.Expected to attract between 400-500 retina specialists from around the world, the meetings' participants will learn about new therapies, recent clinical trial results, artificial intelligence, and the latest retinal imaging technologies. The goal of the conference is to help clinicians better manage their patients with macular and retinal disorders and achieve better patient outcomes in their practices."Our meeting this year promises to provide new insight into current critical issues which are inherent in retinal diseases and their treatments," said K

PR Newswire
Oct 17th, 2023
Vitreous Retina Macula Consultants Of New York Announces Participation In Wet Amd Study In Collaboration With Regenxbio

Currently Enrolling Patients Suffering from Wet Age-Related Macular DegenerationNEW YORK, Oct. 17, 2023 /PRNewswire/ -- Vitreous Retina Macula Consultants of New York ( VRMNY ), the largest retina vitreous center in the New York Metropolitan area, has announced that they have been selected to participate in an innovative Wet AMD study in collaboration with Regenxbio. Wet age-related macular degeneration (wet AMD) is a severe visual impairment caused by the development of new leaky blood vessels in the retina, an essential tissue responsible for vision.VRMNY will be the only Manhattan-based site to participate in the study, which will offer an investigational therapy to patients. The therapy is designed to deliver a targeted gene directly to the retina, in order for these cells to produce an anti-VEGF protein. This groundbreaking approach has the potential to reduce, or even eliminate, the frequent need for anti-VEGF injections, which are the current standard of care for wet AMD.Dr. Richard F